Skip to main content

Ketamine Therapy Offers Hope for Mental Illness Patients

Philadelphia, PA (Newsworthy.ai) Friday May 19, 2023 @ 7:00 AM Central —

Leading experts have shared their insights on the benefits of ketamine as a new form of mental illness treatment. By slowing down the activity of the brain's default mode network, patients can access subconscious thoughts and emotions that may be difficult to reach through other traditional treatments.

Ketamine has shown great promise in treating mental health conditions such as depression, anxiety, and PTSD,". It works faster than traditional antidepressants, with some patients seeing improvement in as little as a few hours. It also has longer-lasting effects than other treatments, with patients experiencing fewer symptoms lasting for weeks or even months.

Patients with treatment-resistant depression have significantly reduced symptoms through ketamine therapy. It also shows great promise in treating suicidal ideation, a significant concern in many cases of severe depression.

This revolutionary treatment transforms mental health and provides hope to countless patients struggling with mental illness. The accessibility of this treatment is also increasing as more providers become trained in administering ketamine infusion therapy.

Scott Integrated Pain Management knows that Ketamine is a new option for treating mental illness, and can provide long-lasting results and hope for a brighter future.

About Scott Integrated Pain Management

Dr. Scott Is An Anesthesiologist And Pain Specialist Practicing In Philadelphia For Whom The Opioid Crisis Has Had A Personal Impact. After Losing A Med-School Classmate, A Co-Resident In Anesthesia, And Two High School Friends To Opioid Overdoses, He Founded Nopium, A Pain Management Consulting and Education Service Dedicated To Providing Effective Pain Relief While Reducing Or Eliminating Opioids.


This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.